Wellington Management Group LLP Verastem, Inc. Transaction History

Wellington Management Group LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.92 - $11.16 $3.77 Million - $45.7 Million	4,096,738 Added 1104.98%	4,467,491 $0
Q1 2022 May 16, 2022	BUY	$1.06 - $2.1 $27,560 - $54,600	26,000 Added 7.54%	370,753 $522,000
Q4 2021 Feb 11, 2022	BUY	$2.05 - $3.2 $706,743 - $1.1 Million	344,753 New	344,753 $707,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.43B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.